Medicine and Dentistry
Neoplasm
66%
Endothelial Cell
66%
Acute Leukemia
61%
Patient
43%
Inpatient
40%
In Vitro
37%
Biological Marker
33%
Phenotype
33%
Tyrosine-Kinase Inhibitor
33%
Procoagulant
33%
Disseminated Intravascular Coagulation
33%
Thrombosis
33%
Hypoxia
33%
Patient with Crohn's Disease
33%
Combination Therapy
33%
Cell Survival
33%
Cell Function
33%
Dasatinib
19%
Therapeutic Procedure
16%
Cell Adhesion Molecule
15%
Intercellular Adhesion Molecule 1
14%
Ponatinib
14%
Association
13%
Nilotinib
11%
Interleukin 6
11%
Interleukin 8
11%
Assay
10%
Programmed Cell Death
10%
Cell Migration
9%
Prognosis
7%
Prostaglandin Synthase
7%
Complication
7%
Thromboplastin
7%
Colon Cancer
7%
Thrombin
7%
Endothelial Leukocyte Adhesion Molecule 1
7%
Atherosclerosis
7%
Vascular Cell Adhesion Molecule 1
7%
Cells
7%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Tyrosine Kinase Inhibitor
100%
Chronic Myeloid Leukemia
71%
Nilotinib
49%
Ponatinib
45%
Dasatinib
44%
Long Term Survival
33%
Rupture
33%
Acute Leukemia
33%
Disseminated Intravascular Clotting
33%
Overall Survival
33%
Crohn Disease
33%
Azathioprine
33%
Survival
33%
Diffuse Large B Cell Lymphoma
33%
Imatinib
22%
Gelatinase A
15%
Gelatinase B
15%
Bosutinib
15%
Cell Adhesion Molecule
12%
Remission
12%
Gelatin
8%
Atherosclerosis
7%
Intercellular Adhesion Molecule 1
7%
Vascular Cell Adhesion Molecule 1
7%
E-Selectin
7%
Blood Vessel Occlusion
6%
Cardiovascular Risk
6%
Artery Occlusion
6%
Randomized Clinical Trial
6%
Comorbidity
6%
Myeloid Leukemia
6%
Matrix Metalloproteinase
6%
Metabolic Syndrome X
6%
Randomized Controlled Trial
5%
Random Effects Model
5%
Lactate Dehydrogenase
5%
Necrosis
5%
Apoptosis
5%
Atherogenesis
5%
Biochemistry, Genetics and Molecular Biology
Overall Survival
40%
Cisplatin
33%
Cancer Cell
33%
Tyrosine Kinase Inhibitor
33%
Association
33%
Disseminated Intravascular Coagulation
33%
Phenotype
33%
Taxonomy
33%
Myeloid
33%
Clinical Study
33%
MicroRNA
33%
Interleukin 6
20%
Interleukin 8
20%
Protein
20%
Nilotinib
16%
Ponatinib
16%
Tumor Progression
13%
Adhesion
13%
Intercellular Adhesion Molecule
13%
Prostaglandin-Endoperoxide Synthase 2
13%
Colon
13%
Ultracentrifugation
11%
Dasatinib
11%
Imatinib
11%
DNA Repair
6%
Chemosensitivity
6%
Messenger RNA
6%
Leukocytes
6%
Inflammatory Cytokine
6%
Molecule
6%
Messenger RNA
6%
Cell Proliferation
6%
Flow
6%
Murine
6%
Tumor Necrosis Factors
6%
Transmembrane Protein
6%
Anticancer
6%
Aggressiveness
6%
Monocyte
6%
RNA Sequence
6%
Stromal Cell
6%
Inhibitor of Apoptosis
6%
Oxygen Tissue Level
6%
Mouse
6%
Macrophage Inflammatory Protein
6%
Time
5%
Randomized Clinical Trial
5%
Data Base
5%
Cochrane Library
5%
Scopus
5%